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1. Introduction 
Both in developed and under developed countries the total number of obese people and 
their fraction of the population are increasing, and they live longer. The need for bariatric 
surgery is rapidly increasing (Buchwald, 2009) and the concept of fast-track surgery and 
laparoscopy (Kehlet, 2008) has made bariatric surgery a cost-effective and efficient way of 
treating the morbididly obese when other non-surgical options have been unsuccessful.  
Whereas ambulatory care is evolving for medium invasive bariatric procedures (i.e. 
gastric banding or minor laparoscopic procedures) in some places, most bariatric patients 
are still in-patients, although a short stay and accelerated recovery should be feasible and 
encouraged (Raeder, 2007).  There is a general trend, especially in the obese, to supply 
anesthetic care with loco-regional techniques whenever possible (Raeder 2010a). This has 
to do with less physiologic and especially respiratory physiologic, derangement, when 
loco-regional techniques are used instead of general anesthesia. Also, as ultrasound 
technology has emerged as a valuable tool in locating regional anesthesia bone-marks in 
the obese, the use of brachial plexus techniques and spinal/epidural techniques has 
grown in the obese. Still, the bariatric procedures usually imply an upper abdomen 
surgical procedure and a predominantly laparoscopic approach. This kind of surgery is 
hard to do with success and patient satisfaction in the awake, even if they have a perfect 
spinal or epidural anesthesia. Similarly local anesthesia is not possible to apply 
sufficiently for laparoscopy, both due to the complexity of anatomical structures involved 
and the risk of toxicity from high total doses of local anesthetic agents.  Still, local 
anesthesia is a very valuable, many will say mandatory, supplement to general anesthesia 
in these patients for improved postoperative pain management, together with other 
measures (see later). There are hardly any reports on bariatric surgery in epidural or 
spinal anesthesia, but there are a very few scattered reports on use of epidural pain relief 
for the postoperative period (Kira, 2007; Nishiyama 2011). Considered the technical 
challenge with these techniques in the obese and the modest pain problems in these 
patients when a proper multimodal approach is used, almost all anesthesiologist will 
abstain from using regional techniques in these procedures. 
www.intechopen.com
 
Advanced Bariatric and Metabolic Surgery 
 
144 
2. Preoperative concerns 
Obese patients may present for any kind of surgery throughout their life; minor or major, 
emergency or elective, well prepared or with severe concomitant problems. Many general 
precautions and warnings linked to anesthesia in these patients are based on worst case 
scenario in an unstable and poorly prepared patient. The bariatric patient, although quite 
huge per definition, is still in many ways less problematic. They are highly motivated, well 
prepared – often through weeks, they are usually young or middle aged, and they usually 
understand that their cooperation and own efforts are very important during the recovery 
phase. 
Although the obese has reduced physiologic reserves, both cardiovascular and respiratory; 
the obesity per se is usually not a major risk factor or reason for not accepting these patients 
for general anesthesia and bariatric surgery (Dindo, 2003). The rare non-acceptance of these 
patients has to do with the total picture of obesity, co-morbidity, preparation, co-operation 
and potential for improvements by postponing the procedure and spend some efforts in 
medical optimization. 
The list of co-morbidity which are more frequent in the obese population include: diabetes, 
hypertonia, gastro-oesophageal reflux, artrosis and musculo-sceletal pain, sleep apnoea 
syndrome and in more severe cases pulmonary hypoventilation and atelectasis or heart failure 
(Chung 1999). It is beyond the scope of this chapter to go in depth with these concomitant 
diseases; the reader is advised to look in general anesthesia textbooks (Raeder 2010a). 
Useful tests are ECG, spirometri, resting bloodgas while breathing room-air, pulmonary x-
ray and a functional test, such as walking a flight of stairs. 
Baseline blood pressure is important to obtain.  Also, a 12-lead routine ECG should be taken 
in these patients upon age above 40 yrs or any suspicion of cardiovascular disease. Still, 
many important aspects of the ECG will be displayed anyway on the one-lead routine 
monitoring peri-operatively. The one-lead ECG is displayed before any drugs are given and 
will tell you about arrhythmia, P-Q prolongation or heart block and any ST segment 
changes in the pre-cordial area. What you will miss by a one-lead ECG are signs of 
heartfailure, hypertrophia and previous infarction.  
Body mass index is the most common way of classifying obesity, and this figure is also 
useful for the anaesthesiologist for classification, risk-stratifying and need of extra consults 
and measures. However, for dosing of anesthetic drugs, different weight concepts are more 
useful. Some definitions of weight is listed in the frame below: 
Different types of weight:
 Actual weight : = Total weight
 Ideal weight:  Height ÷ 100 (105 in women)
 Lean weight:  = fat-free body mass
 Corrected ideal weight:
= ideal weight + 20-40% (?) of difference to actual
weight
 Body mass index: weight / height x height  
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2.1 Concomitant pulmonary disease 
Breathing disorders may be classified into problems of airways and lungs, problems with 
respiratory control and problems of muscular function for breathing. In patients with 
respiratory problems, especially chronic obstructive disease, it may be useful to refer the 
patient to a physiotherapist in advance in order to clean up and get instructions on how to 
cough, breathe and mobilize lungs after surgery. 
Patients with an episode of airway infection should generally be postponed until 1-2 weeks 
after the infection is fully resolved. Postoperative sore-throat or coughing may be a problem 
being no good for the healing after a bariatric surgical procedure, thus also mild viral 
symptoms should call for postponing the case. 
As with all patients;  stop of smoking at least 4-5 weeks before scheduled surgery will 
improve the respiratory function, and this is especially valuable in the obese because they 
are more prone to airway problems than others. Also, smoking may impair wound healing. 
Offering the patients this kind of elective, planned surgery may also be a good opportunity 
to try to convince patients to stop smoking, and some clinics even put this token of patient 
cooperation as a condition for being accepted for surgery. Stopping 1-3 weeks before 
surgery, if the patient is a daily smoker, is not advised; as airway reactivity and secretions 
may be temporarily increased for some weeks after stop of smoking. If stop of smoking is 
not possible, they should at least not smoke on day of surgery, as even a single cigarette will 
result in some carboxy haemoglobin formation which will reduce the oxygen binding 
capacity of blood for some hours afterwards.  
 For patients with severe airway or pulmonary disease or infections, a more thorough 
approach should be undertaken for preoperative evaluation. Patient history with ability to 
walk one flight of stairs, the amount of coughing and secretion, as well as episodic changes 
versus stability in condition should be taken.  Preoperative lung x-ray, arterial blood gas 
and spirometry with vital capacity and forced expiratory volume (FEV1), with and without 
bronchodilator are further options. Generally, a vital capacity of less than 1.5-2 litres in an 
adult or a FEV1 Less than 1-1.5 liter should indicate increased likelihood of severe problems 
and need of ventilatory support post-operatively. 
2.1.1 Sleep apnoea syndrome (SAS) 
Sleep apnoea syndrome is under diagnosed, but probably occurs in 4% of adult male 
population and 2% of females. It is associated with obesity and also with large tonsils or 
adenoids, especially in small children, but could be present without any of these (Young, 
1993).  Although these patients manage someway at home preoperatively the chance of 
respiratory arrest will be increased especially first night after surgery in general anesthesia 
or any use of post-operative opioids. Although fatalities are very rare, 8 cases were reported 
in a big US survey (Lofsky, 2002), one case is one too much and could be avoided by 
overnight continuous monitoring of respiration, either by pulse-oxymetri or better with 
respiratory rate monitoring of some kind (see below).    
The symptoms  of SAS almost always include snoring but should be accompanied with 
more problems to make the diagnosis: respiratory arrest ( > 10 sec), frequent change in 
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position during sleep, tired in spite of normal ”length of sleep”, morning headache and 
family history of SAS (Chung, 2008). A more specific and detailed diagnosis could be made 
with polysomnography done well in advance, and then eventually fit and become familiar 
with using a CPAP device. Patients with a CPAP device should be urged to bring this with 
them on day of surgery, in order to have ready for use in the PACU if needed and 
mandatory use the first nights.  
During polysomnograpy the patient is monitored continuously during full overnight sleep 
with pulse oxymeter, ECG, number and lengths of apnea episodes etc. More than 30 
episodes of hypopnoea or apnea per hour signal a serious condition, whereas less than 15 is 
mild.  A fairly precise prediction of a serious condition could be made clinically if the 
patient tests positively on these four anamnestic items: load snoring (heard through wall or 
door), observed apnea during sleep, tired in spite of normal length of sleep in bed, 
hypertension (Chung, 2008).  
A rational approach to these patients may be (table): 
Known SAS: 
 If treated with CPAP  OK * 
 If minor surgery with no opioids postop  OK 
 If seriously affected SAS and use of opioids  Continuous respiratory monitor!  
Suspected SAS: 
 If serious symptoms  polysomnography (or continous monitor) 
 Mild symptoms (not tired, no major apnoea or distress) 
  OK if not opioid effects after discharge to ward 
 Otherwise: monitor 
No SAS mentioned: 
 Ask for symptoms, partner/comparent information  
 If in doubt  = suspected and plan with monitoring 
*It has been shown that SAS patient who use a CPAP will not have increased risk of apnoea, 
even during first night after surgery. 
Importantly, when these patients are considered to be extra risk, ordinary stay at the ward 
will not be good enough; they have to be monitored continuously during the night. A pulse 
oxymeter may do, although signs of hypoxia are somewhat delayed, even better is a 
respiratory rate monitor with alarm of apnoea. Such respiratory rate monitoring may be: 
end-tidal CO2, breast cage movements or respiratory sound monitor on neck. 
2.2 Patients with cardio-vascular disease 
Generally; a patient who is unable to climb 1 flight of stairs in normal speed without 
cardiovascular symptoms (angina or heart failure, dyspnoea), have a recent cardiac event 
(infarction, revascularisation) within last 3 months or have a serious unstable condition or 
serious limitation in activity; should be postponed and go to cardiology consult and be 
optimized before elective surgery.  
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2.3 General advices and measures in advance 
Especially when these intra-abdominal bariatric procedures (laparoscopy, laparotomy) is 
planned, it is a good safety advice to make the patient reduce even a minor bit in weight 
during the weeks ahead of surgery, by using a high protein-low carbohydrate diet. The 
reason is that most obese have an enlarged and fragile fatty liver. By diet and weight 
reduction for some weeks, the liver will shrink and become less fragile. This may be 
important in order to facilitate surgical access in the abdomen and reduce the risk of liver 
tear or bleeding. 
In the obese patients gastro-oesophageal reflux disease (GERD) occur in about 20-30% of 
cases, and these patients may be at risk for peri-operative regurgitation of acid stomach juice 
into the airways. A good way of reducing both amount and acidity of the gastric content is 
to use a proton pump inhibitor (e.g. omeprazole or other).  The first dose should be at least 
some hours ahead of surgery, but best if already given the evening before and then repeated 
on morning of surgery. If this had not been accomplished, some sips of non-pulmonary 
toxic fluid antacid (sodium-citrate) in front of anesthetic induction may be an alternative 
solution, although not so effective as a proton pump inhibitor. 
As to fasting rules, the gastric emptying speed in obese patients is similar as to lean 
patients (Soreide, 2005). Thus, if no physiologic cause of gastrointestinal obstruction or 
slowing is evident, they should have nothing to eat (including milk and milk products) 
for the last six hours in front of surgery and no clear fluids for the last 2 hours. Still, some 
preoperative tablets may be allowed in a few sips of water up to 1 hour ahead of 
anesthetic induction.  
2.3.1 Premedication 
Due to the increased incidence and risk of airway obstruction in the obese patients, one 
should generally be restrictive with anxiolytic or opioid premedication. If there is a strong 
indication, an oral benzodiazepine may be used, either the short acting midazolam (5-7.5 
mg orally) or more longacting diazepam, 5-15 mg. The patients should then not be left 
alone, but have attendance or pulse-oximetry applied. Establishing an IV line in the ward 
for premedication will enable a more precise targeting of effect, both because midazolam 
or diazepam may be carefully titrated and also because rapid injection of the 
benzodiazepine antagonist, flumazenil, is an option if needed for overdosing or 
respiratory problems. Establishment of an IV line on the preoperative ward is also a good 
measure in terms of avoiding stress and time consuming search for a vein in the busy 
operating room (OR) just before start of anesthesia. Whereas the usual veins on the 
dorsum of the hand may be difficult to find in the obese, the thin volar veins are usually 
accessible without covering fat pads. It may also be a case for ultrasound location of veins 
in these patients, either in the elbow or the medial upper arm (basilica vein) or the central 
veins (internal jugular or subclavian) in the more difficult cases.  Opioid premedication 
should only be used when needed for pre-operative pain, and then in titrated iv doses 
with subsequent monitoring. 
The time for potential premedication, 1-2 hours ahead of surgery, may be a time for giving 
other drugs of benefit for the patient such as oral analgesics (paracetamol and NSAIDs or 
cox-II inhibitor) or prophylactic antibiotics or thrombosis prophylaxis. As the obese are 
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more prone to both thrombosis, pulmonary embolism and wound infections in general, and 
even more so with intra-abdominal surgery,  appropriate  antibiotic (e,g. Cefuroxim 1.5g) 
and  antitrombotic (e.g. low molecular heparine 5000IU sc, day before and every day for one 
week)  is usually indicated. 
3. Anesthetic technique 
3.1 Surgeons contribution 
Even though general anesthesia is needed, it is very important that the surgeon use an 
optimal protocol of local anaesthesia extensive infiltrated in wound areas and surrounding 
structures (LIA-technique) in order to reduce postoperative opioid consume. The surgeon 
should typically use a total of 40 mls of either bupivacaine 2.5 mg/ml or ropivacain 2.0 
mg/ml for superficial and deep wound infiltration. If more than 40 ml is needed, 
ropivacaine should be the drug of choice, as the toxicity from general absorption is less than 
with bupivacaine. Whether the injection should be done at the start of surgery or at the end 
is disputed. Injection at the start will potentially contribute to preoperative analgesia, but 
the resultant effect on general anesthetic dose reduction has been none or negligible in most 
studies. With injection by the end, the effect will last longer than if the injection is done 1-2 
hours previously. Some surgeons may even prefer to do both; before and at the end.  The 
injection initially may then be with a rapid and shortacting agent such as 5-10 mg/ml 
lidocaine, eventually with a vaso-constructive agent (i.e. epinephrine added) in order to 
reduce wound bleeding.  
There are also some studies in the literature advocating installation of local anesthesia in the 
peritoneal cavity (Kahokehr, 2011). This seems to be more effective for dedicated upper 
abdominal surgery, such a liver or gallbladder surgery, whereas the effect in general 
laparoscopy, such as bariatric, is more doubtful.  Whatever local anesthesia techniques are 
used, the surgeon should take care to obey the rules of maximal doses for general toxicity of 
the drugs, and these considerations should be based on mg local anesthesia per kg ideal 
weight, not actual weight. 
The obese patient will generally benefit from spending as short time as possible on the 
operating table, thus, a rapid and technical accurate surgeon is very highly appreciated in 
these patients.  
3.2 For the anesthetist 
Tthe goal will be to have proper anesthesia when needed, but a rapid emergence and 
resumption of adequate respiration and physiology very shortly after the end of the 
procedure (Bergland, 2008). Anything done to minimize the need of postoperative opioids 
and minimize the risk of postoperative nausea and vomiting is very valuable. 
3.2.1 Issues for general anesthesia induction (see also recipe) 
Usually it will be possible to find an IV access in these patients, for instance at the inside of 
the lower underarm there are some thin veins not covered by fat. However, occasionally 
there may be an indication for ultrasound guided access to a central vein if nothing else is 
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possible (see above). The patients should be with 20-30 degrees elevated trunk (half-sitting) 
during induction, preferably be a special pillow or by adjusting the operation table. This 
position has three functions: it will prevent regurgitation,  improve lung function (compared 
to supine) and also facilitate mask ventilation and laryngoscopy for intubation. A potential 
drawback may be increased risk of hypotention after induction with this position, thus 
titrated dosing is advisable and a ready availability of vasopressors, such as ephedrine or 
fenylefrine.  Also a rapid running infusion of crystalloid or colloid is useful. Rapid sequence 
induction is not needed in these patients if they otherwise fulfil fasting criteria. In case of 
rapid sequence induction there may be a case for high dose rocuronium (i.e. 0.8-1.2 mg/kg 
ideal weight) instead of suxamethonium, as the latter is associated with an increased risk of 
anaphylactoid reactions compared with the non-depolarising agents. 
Proper pre-oxygenation with a tight fitting mask and PEEP of 10 cm H2O is very useful, 
and shown to result in an extra 1-2 minutes before de-saturation occurs, if some airway 
problems arise later on. An end-tidal oxygen concentration of 80-90% on mask is a good 
sign of successful pre-oxygenation. Laryngeal mask airway (LMA) and spontaneous 
ventilation is basically beneficial for minimizing airway reactivity and optimizing lung 
physiology, especially in the obese. However, in the obese there is a need for high 
inspiratory pressure in order to overcome the resistance of the fat-coat surrounding the 
rib cage. With an LMA this higher pressure may result in inspiratory leakage, and 
frequently transition to endotracheal tube is needed. With laparoscopy and bariatric 
surgery even more so, because there is a considerable intrabdominal pressure adding to 
the resistance during inspiration.  In conclusion, endotracheal intubation is recommended 
as routine airway management in these patients (Raeder, 2010a). Intubation may be 
achieved with propopfol + remifentanil only, but the high dose need and subsequent risk 
of hemodynamic instability makes the use of non-depolarising neuromuscular blocking 
agent a better choice.  The intubation conditions will be more reliable and the anesthetic 
agents may be kept lower in dosing.  After intubation, a recruitment manoeuvre is 
beneficial to blow up the lungs, and then maintain a PEEP of 10 cm H2O throughout the 
case, with a new recruitment before extubation. Whereas pressure control ventilation 
mode is better for lung physiology, the volume mode is safer in terms of delivering a 
proper and fixed tidal-volume, which again should be adjusted to ideal weight, 6-8 
ml/kg. Especially during laparoscopy the high and variable peritoneal pressure may 
result in very low or variable tidal volumes with the pressure control mode, unless the 
settings are frequently adjusted. 
Recommended drugs for induction will be propofol + remifentanil (see recepe below) 
3.2.2 Issues during maintenance 
All the fat soluble agents are problematic to dose in the obese, because they distribute 
according to slightly more than ideal weight at start (i.e. corrected ideal body weight) and 
then more and more to total weight as the fat gets slowly loaded with drug (Servin, 2006; 
Raeder 2010a). An exception is remifentanil which is degraded before diffusing into the fat, 
and thus is very suitable for continued use in the obese. Propofol may be used for induction 
according to corrected ideal weight, but maintenance beyond 30-60 min calls for increase in 
dose, which is best titrated by using a brain function monitor, such as the BIS or similar 
device. Among inhalational agents, desflurane is the best in terms of less tissue binding and 
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more rapid emergence compared with the other potent inhalational agents. Still, sevoflurane 
or even isoflurane may be used in these patients, but then more care is needed to taper 
down the concentration during the last part of the operation in order to ensure reasonable 
fast emergence (Baerdemaeker, 2003).  Nitrous oxide is very rapidly acting and rapidly 
eliminated, but the potency is low and this agent may only be used as an adjunct to either 
propofol or a potent inhalational agent for anesthetic maintenance. 
3.2.3 Issues for ending the case and postoperative issues 
With dedicated use of maintenance drugs, it should be possible to have a rapid emergence, 
and extubation, also in the obese bariatric cases. It is very important to be generous with 
anti-emetic prophylaxis in these patients as well as providing an optimal non-opioid 
analgesia (see below). The patients should be awake within 5 min to an extent enabling 
them to help in transfer from the operating table to the bed. During transport to the 
postoperative care unit, the patients should be laying on the side, with the head lightly 
elevated, 2-3 litres of oxygen per min by nose catheter. A pulse-oxymeter should be 
connected during the transport to recovery, as well as during the recovery stay.  In the 
PACU, half sitting position should be rapidly encouraged and the patients should be tested 
for breathing room air when they are reasonable awake. A pulse-oxymeter saturation on 
room air of 92% or more is satisfactory. With such a value or higher the patient should not 
have oxygen supply. It has been shown that oxygen supply when not needed, may increase 
the risk of micro-atelectasis in the lung.  Further monitoring in the PACU will include 
regular non-invasive blood-pressure measurements and continuous ECG registration. When 
the patient is fully awake, monitoring may be limited to pulse-oxymeter only. Slow 
intravenous fluid from the period of surgery may be continued until the patients drinks, 
typically an amount of 1-2 litres of krystalloid iv solution is sufficient for the total peri-
operative period, unless there has been significant blood-loss.  
Within 2-4 hours the patients should be able to mobilize on the floor, and be ready for 
discharge to the ward. 
3.2.4 Prophylaxis and treatment of pain, nausea and vomiting 
These are the most common and bothersome complications in the first period after surgery, 
and every measure should be taken to avoid and minimize the occurrence. The two 
important common principles for avoiding these complications will be to think prophylactic 
and multimodal. Multimodal means to address the problem with different drugs of different 
but additive analgesic action mechanisms and different potential and type of side-effects 
(Raeder, 2010a).   
3.2.4.1 Postoperative pain 
For pain the idea is to use as many different non-opioid additive acting analgesics as 
possible in order to minimize the need for opioids (Raeder, 2010a). As opioids should be 
used and given on top when necessary, they carry some dose-dependent side-effects which 
are non-beneficial in the postoperative period. These include: somnolescense, nausea, 
constipation, disrupted sleep pattern, and the more rare and serious respiratory depression 
and sleep apnea syndrome. While opioids usually are needed in small, titrated doses in 
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bariatric patients, the potential of non-opioid pain prophylaxis and treatment should be 
addressed first.  
The concept of starting analgesic treatment before start of surgery in order to reduce 
nociceptive input to central pain mechanisms is disputed, while everyone agrees upon the 
use of having proper pain prophylaxis established when the patients awake from general 
anesthesia shortly after end of the procedure is well established.  
Drugs useful in this context include (Raeder, 2010): 
a. Local wound anesthesia: This should be given by the surgeon either at the start or at the 
end of the procedure (see above). If a particular wound is especially painful after 
surgery, the infiltration may be repeated (bupivacaine 2.5 mg/ml, 5-10 ml per wound) 
every 5-10 hrs, but this is rarely indicated.  
b. Paracetamol: Although a fairly week analgesic the incidence and type of side-effects are 
low, as long as high total doses with potential liver toxixcity is avoided. Paracetamol 
may be used in virtually all patients. It is very well and completely absorbed after oral 
administration and may be started 1-2 hours before surgery, while the alternative may 
be to start with an IV infusion at the start of surgery. The initial dose should be 2 g (1-2 
g if IV), while the continued dosing should be 1 g bid 4, either orally or IV as long as the 
patient have some pain, that is for 4-7 days usually. 
c. Non-steroidal analgesic drugs (NSAIDs): These are very useful analgesic drugs which 
may be used in most patients unless clearly contra-indicated. All NSAIDs carry a risk of 
renal failure upon hypoveolemia, and gastrointestinal ulceration and bleeding. In the 
bariatric setting the new subtype of cox-II selective NSAIDs (i.e. coxibs: celecoxib, 
etoricoxib, lumiraccoxib, parecoxib) have some beneficial characteristics and should 
therefore be preferred. They have less risk of allergy and asthma, they have no 
influence on trombocyte adhesion and no risk of bleeding, and the chance of 
developing gastric ulceration is less than with traditional NSADs (i.e. naproxen, 
ibuprofen, ketprofen, diclofenac). While an overt gastric ulcer or recent story of such is 
an absolute contraindication to these drugs, the coxibs may be used in patients with a 
cured gastric ulcer. Gastric regurgitation is no definite contraindication, unless there are 
overt wounds in the oesophagus. The combination of proton-pump inhibitor and a 
coxib is usually well tolerated, also as gastric regurgitation is mostly a defect in gastro-
oesophageal sphincter and not a change in gastric juice or gastric mucosa constitution.  
The potential negative impact from NSAIDs on gastric anastomoses healing has not 
been proved; on the contrary the opioid sparing effect on gastric motility from using 
NSAIDs may be beneficial in this context. The much disputed risk of cardiovascular 
complications with these drugs is usually not relevant as these are long-term use effects. 
Still, all these drugs may cause some initial fluid retention and slight increase in blood-
pressure, which should be monitored in high risk-patients. 
d. Glucocorticoids: Although a lot of potential side-effects may occur with long term 
treatment, the beneficial analgesic and anti-emetic effect of a single dose perioperatively 
lasting up to 2-3 days is very useful. As the onset of action is slow (2-3 hours) a 
glucocorticoid is best given at start of surgery. Dexamethasone is most popular, because 
it is a pure glucocorticoid with minor effect on electrolyte and mineral balance, and 
because duration of a single IV dose is long. It may be wise to give dexamethasone after 
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the patient is asleep as there is a preservative in most dexamethasone solutions which 
may give strong perineal itching when given rapidly in the awake. While the dose of 8 
mg IV has been proven efficacious in general laparoscopy, it may be wise to increase 
the dose to 16 mg in the obese bariatric patient. Alternatives to IV dexamethasone may 
be metylprednisolone (50-125 mg) or oral prednisolone given in advance ( 20-50 mg) or 
oral dexamethasone, 15-25 mg.  As these drugs cause a slight increase in blood-sugar 
level, care should be taken to monitor blood-sugar levels if these drugs are used in the 
diabetic. 
e. Opioids: These may surely be needed on top of the non-opioid multimodal regimen. 
Any opioid may do, but care should be taken to use small and titrated dosing. For that 
reason opioids with rapid onset and short duration, such as alfentanil or fentanyl, are 
most easy to adjust. Initially the IV route is best, for instance using fentanyl, oxycodone 
or morphine. Then, after the PACU period the oral alternative should be preferred. The 
newer opioid subclass of oral opioid agonist with norepinephric effects, such as 
tramadol and tapentadol, has  less risk of respiratory depression, but the incidence of 
nausea and vomiting is quite high, especially with tramadol, whereas tapentadol so far 
seems promising. Buprenorphine is a weaker opioid agonist, but well absorbed orally 
and with long duration of effect and low risk of respiratory depression. Other oral 
alternatives include codeine and oxycodone. Codeine is an inactive prodrug of 
morphine and 5-10% of the population do not have the converting enzyme and then 
they have no effect of the drug. Oxycodone is a potent, well absorbed opioid which may 
be given in rapid acting 5 mg tablets or slow-release formulations of 10-20 mg. Some 
studies show less sedation or somnolescense with oxycodone when compared to 
equipotent doses of morphine (Lenz, 2009). As this opioid also seems to work very well 
on visceral pain, it may be the preferred oral opioid for the bariatric patients. 
f. Other analgesics: There are quite some other non-opioid drugs which have a beneficial 
postoperative analgesic action: ketamine, iv lidocaine, gabapentin, pre-gabalin, 
cannabinoids (Raeder, 2010a). 
The gabapentinoids (gabapentin, pre-gabalin) are well established for postoperative pain 
indication, but they may result in somnolescense, dizziness and fainting initially, when 
dosed to high. In bariatric patients with more than usual pain, these drugs may still be an 
alternative; then a modest starting dose of for instance 75-150 mg pre-gabalin may be tried, 
and then repeated twice a day, eventually increased carefully until 300 mg.  
In the immediate postoperative period a low dose infusion (i.e. 1-2 microg/kg ideal 
weight/min) of ketamin may also be an option in patients with strong pain.  
3.2.4.2 Postoperative nausea and vomiting (PONV) 
This is a troublesome complication in the postoperative, obese bariatric patient and an 
aggressive approach as to multimodal prophylaxis should be applied. The reason for 
multimodality in this context is that no single drug is more than effective in 50% of the 
patients, but with different acting drug combination this incidence may be up in the 80-90% 
range (Raeder, 2010a). The known risk factors of postoperative nausea and vomiting 
include: more than average tendency of travel sickness, more than average nausea after 
general anesthesia, opioid use, non-smoking status, female gender. Also type of surgery, 
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such as laparoscopy, has been associated with higher incidence of PONV, and the use of 
inhalational anesthetic agents as opposed to propofol which is anti-emetic (Apfel, 2004). 
A first measure to reduce the incidence of PONV is to minimize opioid effects and use in the 
postoperative care unit. This is achieved by using optimal non-opioid analgesic prophylaxis 
and treatment, and by using shortacting opioid (i.e. remifentanil) with minimal residual 
effect after general anesthesia.  
Then, secondly,  a mixture of anti-emetic prophylaxis should be used in these patients. 
The basis will be a 5-HT3 blocker (e.g. ondansetron 4 mg) given by end of anesthesia and 
glucocorticoid given by start (see above, glucocorticoid for pain) in all bariatric patients. In 
patients with more than average risk it may be useful to add droperidol 1.25 mg into the 
prophylaxis, and consider ending the anesthesia with a period of propofol infusion instead 
of desflurane all way through.  
If the patient develops nausea in the postoperative unit, it is important to rule out and treat 
some non-pharmacologic reasons for PONV: dehydration, hypotention, hypoxia or sudden 
movement. If anti-emetic drug treatment is needed it is wise to supplement with a drug the 
patient not already has received; that may be either metoclopramid (10 mg iv, eventually 
repeated) or ephedrine 5-10 mg IV. Ephedrine is especially efficient in those patients who 
experience nausea when moving or mobilizing, and if this is a consistent problem a sc 
injection of 25-40 mg ephedrine may be of help.  
In more resistant cases the new class of NK-1 antogonisk anti-emetics may be tried.  
4. Anesthetic recepe 
There are many successfyl ways to run general anesthesia in bariatric surgical patients, 
but this is a well tested recepe, now being applied to more than 2000 consecutive patients 
in a dedicated clinic for these procedures (Bergland, 2008). These patients should have 
standard monitoring with ECG, noninvasive blood pressure measurement, pulse 
oximetry, nerve stimulation test of neuromuscular block (i.e., TOF guard®), end-tidal CO2 
measurement, and anesthetic gas analysis. An arterial line for invasive blood pressure 
measurement is only inserted if specifically indicated, e.g., patients with known 
cardiovascular problems. 
It may be useful to monitor the depth of anesthesia in these patients, but this may be 
skipped during inhalational-based anesthesia if end-tidal MAC values are above 1 MAC all 
the time. 
Our recipe for obese patients undergoing laparoscopy is as follows: 
An iv infusion of 500 ml starch, colloid solution is running rapidly, followed by a slow 
infusion of crystalloid (0.5-1.0 liter during the procedure). 
When preoxygenation is fulfilled, anesthesia is induced with fentanyl 100 micog, propofol 
and remifentanil plasma target controlled infusions (TCI) with targets of 6 microg/ml and 8 
ng/ml, respectively. Both infusions are based on corrected ideal weight (height in 
centimeters minus 100, plus 20% of the difference between the real weight and ideal 
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weight), propofol with the Marsh effect site model and remifentanil with the Minto effect 
site model. 
Then, vecuronium 0.08 mg/kg corrected ideal weight is given. 
Tracheal intubation is performed with the patient in the semi-sitting position with their 
torso flexed and the head extended in the neck (“sniffing the morning air” position). A 
standard laryngoscope with a short handle and an endotracheal tube with a stylet are 
used. 
After the tracheal tube is secured, the propofol infusion is stopped and inhalation of 
desflurane at 3–6 % (i.e., 0.5 – 1 MAC) is started. Inspiratory oxygen is reduced to 40% and 
PEEP to 5 cmH2O. 
A gastric tube is inserted and the gastric content (if any) is aspirated. 
Anesthesia is continued throughout the operation with remifentanil and desflurane. The 
doses are adjusted according to clinical observation, arterial blood pressure, and bispectral 
index (BIS). Typically, remifentanil TCI is adjusted within a wide range to keep systolic 
blood pressure within acceptable limits (i.e., 85–120 mmHg) and desflurane is adjusted to 
keep the BIS within the range of 45–55. If no BIS is available an endtidal concentration of 0.7-
1.0 MAC desflurane should be used. 
Droperidol 1.25 mg, ondansetron 4 mg, and dexamethasone 16 mg are given as routine iv 
antiemetic prophylaxis. 
Parecoxib 40 mg and paracetamol 1g are given iv, and bupivacaine 2.5 mg/ml is infiltrated 
around the incisions, in a total volume of 30–40 ml, to prevent postoperative pain. 
Furthermore, fentanyl 100 microg is given before the end of surgery. 
Desflurane and remifentanil are stopped upon removal of the laparoscope at the end of 
surgery, and a small dose of propofol (30–50 mg total) is then given. The neuromuscular 
block is reversed with neostigmine 2.5 mg and glycopyrrolate 1 mg and the patients are 
ventilated with 100% oxygen. The patients are extubated on the table when they are 
emerging, breathing, and showing the first signs of irritation from the tracheal tube. Then 
patients move themselves, with some assistance, into the bed. 
Analgesia (present at emergence): 
 bupivacaine/ropivacaine wound infiltration 
 paracetamol 1.0 g iv 
 parecoxib 40 mg iv (or ketorolac 30 mg iv) 
 dexamethasone 16  mg iv 
 fentanyl 1–2 microg/kg at the end of surgery 
Anti-emesis: 
 droperidol 1.25 mg iv 
 (dexamethasone, also given for pain) 
 ondansetron 4 mg iv 
 propofol anesthesia + remifentanil anesthesia, no nitrous oxide, low opioid hangover 
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